239 related articles for article (PubMed ID: 28971687)
1. Animal models for autism in 2017 and the consequential implications to drug discovery.
Chadman KK
Expert Opin Drug Discov; 2017 Dec; 12(12):1187-1194. PubMed ID: 28971687
[TBL] [Abstract][Full Text] [Related]
2. Do animal models hold value in Autism spectrum disorder (ASD) drug discovery?
Chadman KK; Fernandes S; DiLiberto E; Feingold R
Expert Opin Drug Discov; 2019 Aug; 14(8):727-734. PubMed ID: 31132011
[No Abstract] [Full Text] [Related]
3. Psychopharmacological interventions in autism spectrum disorder.
Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
[TBL] [Abstract][Full Text] [Related]
4. Neuronal mechanisms and circuits underlying repetitive behaviors in mouse models of autism spectrum disorder.
Kim H; Lim CS; Kaang BK
Behav Brain Funct; 2016 Jan; 12(1):3. PubMed ID: 26790724
[TBL] [Abstract][Full Text] [Related]
5. Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism.
Kim JW; Seung H; Kim KC; Gonzales ELT; Oh HA; Yang SM; Ko MJ; Han SH; Banerjee S; Shin CY
Neuropharmacology; 2017 Feb; 113(Pt A):71-81. PubMed ID: 27638451
[TBL] [Abstract][Full Text] [Related]
6. Modeling autism-relevant behavioral phenotypes in rats and mice: Do 'autistic' rodents exist?
Servadio M; Vanderschuren LJ; Trezza V
Behav Pharmacol; 2015 Sep; 26(6):522-40. PubMed ID: 26226143
[TBL] [Abstract][Full Text] [Related]
7. Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions.
Lacivita E; Perrone R; Margari L; Leopoldo M
J Med Chem; 2017 Nov; 60(22):9114-9141. PubMed ID: 29039668
[TBL] [Abstract][Full Text] [Related]
8. Investigational drugs in early-stage clinical trials for autism spectrum disorder.
Hong MP; Erickson CA
Expert Opin Investig Drugs; 2019 Aug; 28(8):709-718. PubMed ID: 31352835
[No Abstract] [Full Text] [Related]
9. Glutamate-mediated signaling and autism spectrum disorders: emerging treatment targets.
Yang P; Chang CL
Curr Pharm Des; 2014; 20(32):5186-93. PubMed ID: 24410563
[TBL] [Abstract][Full Text] [Related]
10. Behavioral phenotypes and neurobiological mechanisms in the Shank1 mouse model for autism spectrum disorder: A translational perspective.
Sungur AÖ; Schwarting RKW; Wöhr M
Behav Brain Res; 2018 Oct; 352():46-61. PubMed ID: 28963042
[TBL] [Abstract][Full Text] [Related]
11. Oxytocin and Animal Models for Autism Spectrum Disorder.
Wagner S; Harony-Nicolas H
Curr Top Behav Neurosci; 2018; 35():213-237. PubMed ID: 28864977
[TBL] [Abstract][Full Text] [Related]
12. Autism Spectrum Disorders: Translating human deficits into mouse behavior.
Pasciuto E; Borrie SC; Kanellopoulos AK; Santos AR; Cappuyns E; D'Andrea L; Pacini L; Bagni C
Neurobiol Learn Mem; 2015 Oct; 124():71-87. PubMed ID: 26220900
[TBL] [Abstract][Full Text] [Related]
13. What we can learn from a genetic rodent model about autism.
Möhrle D; Fernández M; Peñagarikano O; Frick A; Allman B; Schmid S
Neurosci Biobehav Rev; 2020 Feb; 109():29-53. PubMed ID: 31887338
[TBL] [Abstract][Full Text] [Related]
14. New directions in the treatment of autism spectrum disorders from animal model research.
Chadman KK; Guariglia SR; Yoo JH
Expert Opin Drug Discov; 2012 May; 7(5):407-16. PubMed ID: 22494457
[TBL] [Abstract][Full Text] [Related]
15. Decrease in endogenous brain allopregnanolone induces autism spectrum disorder (ASD)-like behavior in mice: A novel animal model of ASD.
Ebihara K; Fujiwara H; Awale S; Dibwe DF; Araki R; Yabe T; Matsumoto K
Behav Brain Res; 2017 Sep; 334():6-15. PubMed ID: 28743598
[TBL] [Abstract][Full Text] [Related]
16. Current knowledge, challenges, new perspectives of the study, and treatments of Autism Spectrum Disorder.
Lotufo Denucci B; Silva de Lima L; Ferreira Lima Mota I; Rocha Madureira Azevedo J; Germino Veras L; Montenegro Luzardo Bicca JV; de Miranda Santana B; Beserra Pinheiro G; Gonçalves Coelho G; Mortari MR
Reprod Toxicol; 2021 Dec; 106():82-93. PubMed ID: 34695561
[TBL] [Abstract][Full Text] [Related]
17. Autism Spectrum Disorder: Signaling Pathways and Prospective Therapeutic Targets.
Baranova J; Dragunas G; Botellho MCS; Ayub ALP; Bueno-Alves R; Alencar RR; Papaiz DD; Sogayar MC; Ulrich H; Correa RG
Cell Mol Neurobiol; 2021 May; 41(4):619-649. PubMed ID: 32468442
[TBL] [Abstract][Full Text] [Related]
18. From bedside to bench and back: Translating ASD models.
Drozd HP; Karathanasis SF; Molosh AI; Lukkes JL; Clapp DW; Shekhar A
Prog Brain Res; 2018; 241():113-158. PubMed ID: 30447753
[TBL] [Abstract][Full Text] [Related]
19. Zebrafish models of autism spectrum disorder.
Meshalkina DA; N Kizlyk M; V Kysil E; Collier AD; Echevarria DJ; Abreu MS; Barcellos LJG; Song C; Warnick JE; Kyzar EJ; Kalueff AV
Exp Neurol; 2018 Jan; 299(Pt A):207-216. PubMed ID: 28163161
[TBL] [Abstract][Full Text] [Related]
20. Successful Use of Sertindole for Severe Behavioral Dyscontrol in a Pediatric Case of Syndromic Autism Spectrum Disorder.
Naguy A
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):471-472. PubMed ID: 28296430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
